A preprint of a study says that countries with mandatory policies to vaccinate against tuberculosis register fewer coronavirus deaths than countries that don’t have those policies.
March 17, 2020. A clinical trial of investigational vaccine for COVID-19 has begun. Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. Currently (March 17, 2020) no approved vaccines exist to prevent infection with SARS-CoV-2.